Back to Results

Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma with Molecular Correlates

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Phase

II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.

Type of Study

Treatment

Scope

National

Locations

Dana Farber Cancer Institute
Lone Tree Medical Center
Mayo Clinic, Arizona
New York University
University of Arizona Cancer Center
University of Colorado Hospital
University of Kansas Cancer Center

Principal Investigator
Wells Messersmith,  MD

Wells Messersmith, MD

Study ID

Protocol Number: 15-0150

ClinicalTrials.gov: NCT02723331

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers